Gram J, Mercker S, Bruhn H D
Klinikum der Christian-Albrechts-Universität, I. Medizinische Klinik, Kiel, Federal Republic of Germany.
Thromb Res. 1988 Dec 1;52(5):353-9. doi: 10.1016/0049-3848(88)90019-9.
The heparin neutralizing properties of protamine chloride on conventional heparin (porcine mucosa) and on low molecular weight heparin (Kabi 2165) were studied in vitro. Protamine chloride neutralized 99% of the delaying effect of conventional heparin on the activated partial thromboplastin time, whereas only 70% of the effect of low molecular weight heparin was neutralized. The neutralizing effect of protamine chloride on the inhibition of factor Xa (clot test) was 95% for conventional heparin and 55% for low molecular weight heparin, whereas the effect of both heparin preparations on the thrombin inhibition could be completely neutralized. We conclude that conventional heparin is neutralized more effectively in vitro by protamine chloride than is the low molecular weight heparin. The findings do not exclude that protamine chloride is able to suppress in vivo bleedings caused by low molecular weight heparin.
在体外研究了氯化鱼精蛋白对常规肝素(猪黏膜来源)和低分子量肝素(凯比2165)的肝素中和特性。氯化鱼精蛋白可中和99%的常规肝素对活化部分凝血活酶时间的延迟作用,而低分子量肝素的作用仅被中和70%。氯化鱼精蛋白对Xa因子抑制作用(凝血试验)的中和效果,对于常规肝素为95%,对于低分子量肝素为55%,而两种肝素制剂对凝血酶抑制作用的效果均可被完全中和。我们得出结论,在体外,氯化鱼精蛋白对常规肝素的中和作用比对低分子量肝素更有效。这些发现并不排除氯化鱼精蛋白能够抑制低分子量肝素引起的体内出血。